Literature DB >> 32584589

Tubulysin Synthesis Featuring Stereoselective Catalysis and Highly Convergent Multicomponent Assembly.

Thimmalapura M Vishwanatha1, Ben Giepmans2, Sayed K Goda3, Alexander Dömling1.   

Abstract

A concise and modular total synthesis of the highly potent N14-desacetoxytubulysin H (1) has been accomplished in 18 steps in an overall yield of up to 30%. Our work highlights the complexity-augmenting and route-shortening power of diastereoselective multicomponent reaction (MCR) as well as the role of bulky ligands to perfectly control both the regioselective and diastereoselective synthesis of tubuphenylalanine in just two steps. The total synthesis not only provides an operationally simple and step economy but will also stimulate major advances in the development of new tubulysin analogues.

Entities:  

Year:  2020        PMID: 32584589     DOI: 10.1021/acs.orglett.0c01718

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Diastereocontrol in Radical Addition to β-Benzyloxy Hydrazones: Revised Approach to Tubuvaline and Synthesis of O-Benzyltubulysin V Benzyl Ester.

Authors:  Manshu Li; Koushik Banerjee; Gregory K Friestad
Journal:  J Org Chem       Date:  2021-10-12       Impact factor: 4.354

Review 2.  The 100 facets of the Passerini reaction.

Authors:  Luca Banfi; Andrea Basso; Chiara Lambruschini; Lisa Moni; Renata Riva
Journal:  Chem Sci       Date:  2021-09-30       Impact factor: 9.825

Review 3.  Multicomponent Reactions for the Synthesis of Active Pharmaceutical Ingredients.

Authors:  Ángel Cores; José Clerigué; Emmanuel Orocio-Rodríguez; J Carlos Menéndez
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-17

4.  Expeditious Total Synthesis of Hemiasterlin through a Convergent Multicomponent Strategy and Its Use in Targeted Cancer Therapeutics.

Authors:  Jiraborrirak Charoenpattarapreeda; Stephen J Walsh; Jason S Carroll; David R Spring
Journal:  Angew Chem Int Ed Engl       Date:  2020-10-12       Impact factor: 15.336

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.